Home

InvestorNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) and UAV Corp (OTC: UMAV) Appoints New CEO, Launches BioSentry Division for Real-Time Biohazard Detection

Fifty 1 Labs (OTC: FITY), a leader in technology and wellness innovation, has appointed Michael Lawson as CEO and Chairman while launching its new BioSentry Division focused on advanced biohazard detection. The division will develop real-time sensor systems using PCR, spectrometry and AI-driven analytics to detect biological, chemical and environmental threats, with applications spanning defense, public health, and industrial safety. The company also announced a strategic partnership with UAV Corp (OTC: UMAV) to integrate the sensors with UAVs and plans to issue a UMAV share dividend to FITY shareholders. Meanwhile, Fifty 1 Labs has opted not to proceed with the Genetic Networks acquisition and remains focused on securing Department of Defense contracts. Brandon Spikes and Robert Clark will continue in key leadership roles as the company advances its dual focus on safety and wellness technologies.

To view the full press release, visit https://ibn.fm/EMAyM

About Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. (OTC: FITY), a Nevada corporation based at 751 North Drive, Melbourne, FL 32934, is a holding company driving innovation in health, wellness, and biotechnology. FITY owns 100% of Genetic Networks LLC, a Delaware-based biotech firm founded in 2015 by Dr. Gennaro D’Urso. Genetic Networks, headquartered in Miami, Florida, develops the GeneScape™ platform, a yeast-based, whole-genome analysis tool that accelerates drug discovery for personalized medicine, biodefense, and wellness applications, with proven success serving major pharma clients like Bristol Myers Squibb. FITY also wholly owns 51, LLC, its sports nutrition subsidiary offering a premium line of supplements—including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies—designed to enhance athletic performance, recovery, and overall health. The Quickness, Astound NMN, and Drago Knives have been merged out of the company and are no longer part of Fifty 1 Labs, Inc., sharpening FITY’s focus on biotech and wellness synergies to empower individuals and organizations worldwide.

For more information, visit the company’s website at https://fifty1labs.com/

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork